•
Mar 31

Royalty Pharma Q1 2025 Earnings Report

Expected Revenue:$725M
+8.9% YoY
Expected EPS:$1.06
+7.4% YoY
Total Revenue
$568M
Previous year: $568M
+0.0%
Cash and Equivalents
$1.1B
Previous year: $843M
+30.5%
Free Cash Flow
$632M
Previous year: $670M
-5.6%
Total Assets
$17.6B
Previous year: $16.1B
+9.2%

Royalty Pharma

Royalty Pharma